Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro

European Journal of Neuroscience

Volumn 12, Issue 11, 2000, Pages 3833-3842

  Pringle, A K ^a   Self, J ^a   Eshak, M ^a   Iannotti, F ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Hippocampus; Ischaemia; NMDA; Organotypic slice culture; Rat

Indexed keywords

DIZOCILPINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL DEGENERATION; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; DITHIONITROBENZOIC ACID; DITHIOTHREITOL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MEMANTINE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0033769368     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00272.x     Document Type: Article

References (45)

1. The action of CGS19755 on the redox enhancement of NMDA toxicity in rat cortical neurons in vitro
2. Selective modulation of NMDA responses by reduction and oxidation
3. Subunit specific interactions of cyanide with the n-methyl-D-aspartate receptor
4. Redox modulation of synaptic responses and plasticity in rat CA1 hippocarupal neurons
5. Do NMDA antagonists protect against cerebral ischemia: Are clinical trials warranted?
6. Open-channel block of n-methyl-B-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity
7. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: Uncompetitive antagonism
8. Neuroprotective concentrations of the n-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning of long-term potentiation
9. Synaptic plasticity in ischaemia: Role of NMDA receptors
10. The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole proprionate (AMPA) /kainate antagonists and their role in cerebral ischaemia
11. n-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture
12. Anoxic LTP is mediated by the redox modulatory site of the NMDA receptor
13. Autoradiographic characterization of n-methyl-D-aspartate, quisqualate- and kainate-sensitive glutamate binding sites
14. Emerging treatments for stroke in humans
15. The changing landscape of ischaemic brain injury mechanisms
16. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex
17. Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons
18. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide
19. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
20. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal neurons
21. Anatomical distribution of four pharmacologically distinct 3-L-glutamate binding sites
22. Hetereomeric NMDA receptors: Molecular and functional distribution of subtypes
23. Molecular cloning and characterization of the rat NMDA receptor
24. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures
25. Effects of nitroprusside and redox reagents on NMDA receptors expressed in Xenopus oocytes
26. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal slice cultures
27. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischaemia
28. 3H]-MK-801 binding and NMDA-induced calcium fluxes
29. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures
30. Synergism between diltiazem and MK-801, but not APV, in protecting hippocampal slices against hypoxic damage
31. Neuroprotective effect of memantine demonstrated in vivo and in vitro
32. Pathophysiology and treatment of focal ischaemia. Part II: Mechanisms of damage and treatment
33. Intrinsic redox properties of n-methyl-D-aspartate receptor can determine the developmental expression of excitotoxicity in rat cortical neurons in vitro
34. Redox mechanisms at the glutamate synapse and their significance: A review
35. A simple method for organotypic cultures of nervous tissue
36. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists
37. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation
38. 2+ flux in mammalian central neurons
39. Identification of two cysteine residues that are required for redox modulation of the NMDA receptor
40. Triggering and execution of neuronal death in brain ischaernia: Two phases of glutamate release by different mechanisms
41. Cerebral glucose metabolism during the recovery period after ischemia - Its relationship to NADH-fluorescence, blood flow, EcoG and histology
42. The modulation of n-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurons in vitro
43. Direct observation of the agonist specific regional vulnerability to glutamate, NMDA and kainate neurotoxicity in organotypic hippocampal cultures
44. Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro
45. Redox modulation of n-methyl-D-aspartate-stimulated neurotransmitter release from rat brain slices